EIDOS THERAPEUTICS
BridgeBio is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients. The BridgeBio approach combines a traditional focus on drug development with a unique corporate model, allowing rapid translation of early stage science into medicines that treat disease at its source.
EIDOS THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2013-08-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.eidostx.com
Total Employee:
11+
Status:
Active
Contact:
650-656-9920
Total Funding:
64 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Revere Pharmaceuticals
Revere Pharmaceuticals is an oncology-focused biotechnology company leading the development of small molecule therapeutics.
Reactive Medical Labs
Reactive Medical Labs is a biotechnology company developing regenerative skincare applications.
Nirogy Therapeutics
Nirogy Therapeutics is focusing on small-molecule drugs that target the solute carrier family of transporter proteins (SLCTs).
Nano Cures
Nano Cures is clinical-stage biotechnology and infectious disease immunity platform company.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
NextVivo
NextVivo is a biotech company developing an immune organoid technology platform.
Next Science
Next Science pioneers innovative, proprietary technologies to address the problem of biofilm.
MyMeds&Me
My Meds & Me provides a web-based solution for the capture of adverse event, product complaint.
Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Latigo Biotherapeutics
Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
LB Pharmaceuticals
LB Pharmaceuticals specializes in developing a treatment for schizophrenia.
Lactocore
Lactocore is a biotech company that develops novel peptide therapeutics using cutting-edge technologies
AffyImmune Therapeutics
AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.
AlgoTherapeutix
AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Acies Bio
Acies Bio is a biotechnology CRO offering state-of-the-art R&D services to pharmaceutical, chemical, biotech and food industries.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Arcutis Biotherapeutics
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Eirion Therapeutics
Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Endonovo Therapeutics
Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products.
Everest Clinical Research
Everest Clinical Research is a firm which conducts clinical research by contract for firms across the globe in fields
Emerald Health Pharmaceuticals
EHP is a biotech company developing biotechnology and cannabinoids science and technology to treat incurable diseases.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Eliem Therapeutics
Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.
Iterion Therapeutics
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
BioVaxys
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.
Faraday Pharmaceuticals
Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.
Telomere Therapeutics
Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
Teon Therapeutics
Teon Therapeutics is a a biopharmaceutical company developing small molecules that inhibit the immunosuppressive cancer signaling pathways.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Synaptogenix
Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
Selecta Biosciences
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Dermira
Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.
HDT Bio
IMMUNE THERAPY FOR ALL: We’re transforming inventive immunotherapies for oncology and infectious disease.
InventisBio
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Intabio
Intabio is a developer of a real-time protein analytics platform used to transform the development of biotherapeutic drug.
Genascence
Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases
Gem Pharmaceuticals
Gem Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically
Glycomine
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
GH Research
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Ocuphire Pharma
Ocuphire Pharma, a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.
Oncopeptides
Oncopeptides AB is a privately held clinical stage company developing melflufen, a peptidase potentiated therapy for multiple myeloma.
Cirius Therapeutics
Cirius Therapeutics is a clinical-stage company that develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
Zentalis Pharmaceuticals
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Hepion Pharmaceuticals
Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.
Chamishi Therapeutics
Chamishi Therapeutics is a drug discovery and development company focused on neurodegenerative diseases and other related disorders.
CiVi Biopharma
CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Curevo
Curevo is a clinical-stage biotech firm focused on producing next-generation vaccines.
Cadence Health
Cadence, a pharma startup, aims to switch a birth control pill over-the-counter to create easy and affordable access to contraceptives.
Galectin Therapeutics
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
Current Advisors List
Board_member
2020-08-01
Board_member
2016-03-01
Board_member
2018-03-01
Board_member
2018-12-01
Board_member
2018-03-01
Current Employees Featured
Mamoun Alhamadsheh Scientific co-Founder @ Eidos Therapeutics
Scientific co-Founder
2013-08-01
Uma Sinha Chief Scientific Officer @ Eidos Therapeutics
Chief Scientific Officer
2016-06-01
Jonathan Fox President and CMO @ Eidos Therapeutics
President and CMO
2016-10-01
Isabella Graef Co-founder @ Eidos Therapeutics
Co-founder
Neil Kumar Chief Executive Officer @ Eidos Therapeutics
Chief Executive Officer
2016-03-01
Founder
Stock Details
Investors List
BridgeBio Pharma
BridgeBio Pharma investment in Series B - Eidos Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - Eidos Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Eidos Therapeutics
Aisling Capital
Aisling Capital investment in Series B - Eidos Therapeutics
Amzak Health Investors
Amzak Health Investors investment in Series B - Eidos Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Eidos Therapeutics
Janus Henderson
Janus Henderson investment in Series B - Eidos Therapeutics
Viking Global Investors
Viking Global Investors investment in Series B - Eidos Therapeutics
Newest Events participated
Official Site Inspections
http://www.eidostx.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.32 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Eidos Therapeutics"
Eidos Therapeutics - Crunchbase Company Profile
Organization. Eidos Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email info@eidostx.com; Phone Number 650-656-9920; BridgeBio is a clinical …See details»
Eidos Therapeutics Company Profile 2024: Valuation, …
Information on acquisition, funding, cap tables, investors, and executives for Eidos Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Eidos Therapeutics Information - RocketReach
Eidostx.com; hotmail.com; 1 208363XXXX; View Similar People. Related Companies Presidio Graduate School. 83 $3m Peerspace. 102 $20.2m The James Irvine Foundation. 90 5AM …See details»
Eidos Therapeutics - Overview, News & Similar companies
View Eidos Therapeutics (www.eidostx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Eidos Therapeutics Company Profile | Management and ... - Datanyze
Smith@eidostx.com: Eidos Therapeutics Top Competitors. Company Employees Revenue Top technologies; TRACON Pharmaceuticals Inc. 18: $9 M: Spruce Biosciences Inc. 31: $7.4 M: …See details»
What is ATTR? | TTR Life-Cycle | Eidos TX - BridgeBio
Sep 27, 2024 transthyretin (TTR) TTR is a highly evolutionarily conserved protein that has been found to circulate in the blood of all vertebrates. As a circulating protein primarily made in the liver, TTR plays a key role in the …See details»
Eidos Therapeutics - Company Profile - Tracxn
Nov 27, 2024 Eidos Therapeutics, a BridgeBio company, is developing small molecule treatment for transthyretin (TTR) amyloidosis (a rare disease). Its lead product AG10 is a small molecule …See details»
Eidos Therapeutics Overview | SignalHire Company Profile
Eidos Therapeutics is a public company that has been in the industry for 11 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Co …See details»
BridgeBio Completes Merger with Eidos | BridgeBio
Jan 26, 2021 BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc. PALO ALTO, CA – January 26, 2021 – BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: …See details»
Eidos Therapeutics - Craft
Jan 28, 2021 Eidos Therapeutics is a biotech company developing novel, genetically targeted therapies to improve the lives of patients. The Company's approach combines a traditional …See details»
Eidos Therapeutics: Employee Directory | ZoomInfo.com
Eidos Therapeutics Employee Directory . Eidos Therapeutics corporate office is located in 101 Montgomery St Ste 2550, San Francisco, California, 94104, United States and has 63 …See details»
Eidos Therapeutics CEO and Key Executive Team | Craft.co
Eidos Therapeutics's Chief Executive Officer is Neil Kumar. Other executives include Jonathan Fox, President and Chief Medical Officer; Uma Sinha, Chief Scientific Officer, Director and 3 …See details»
BridgeBio Pharma, Inc. Announces Completion of Merger with …
For more information, visit www.eidostx.com. Forward-Looking Statements This press release contains forward-looking statements relating to the proposed transaction involving BridgeBio …See details»
FDA Grants Orphan Drug Designation to Eidos | BridgeBio
Oct 3, 2018 For more information, please visit www.eidostx.com. Forward-Looking Statements. This release includes forward-looking statements within the meaning of Section 27A of the …See details»
BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce …
Jan 13, 2021 PALO ALTO, Calif. and SAN FRANCISCO, Jan. 13, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) and Eidos Therapeutics, Inc. (“Eidos”) …See details»
BridgeBio Pharma and Eidos Therapeutics Announce Merger …
Oct 5, 2020 PALO ALTO, Calif. and SAN FRANCISCO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a company focused on genetic diseases, and Eidos …See details»
BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. - GlobeNewswire
Jan 13, 2021 In addition, the documents filed by BridgeBio may be obtained free of charge from BridgeBio at investor.bridgebio.com, under the tab “Financials & Filings,” and the documents …See details»
Stockholders of BridgeBio Pharma, Inc. and Eidos ... - BioSpace
Jan 19, 2021 In addition, the documents filed by BridgeBio may be obtained free of charge from BridgeBio at investor.bridgebio.com, under the tab “Financials & Filings,” and the documents …See details»
BridgeBio Pharma, Inc. Announces Completion of Merger with …
Jan 26, 2021 For more information, visit www.eidostx.com. Forward-Looking Statements This press release contains forward-looking statements relating to the proposed transaction …See details»
ISS Recommends Stockholders Vote “FOR” Merger | BridgeBio
Jan 4, 2021 For more information, visit www.eidostx.com. Additional Information and Where to Find It: This communication is being made in respect of the proposed transaction involving …See details»